Related Experiment Video

Updated: Jan 11, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.4K

Successful Treatment of Post-Transplant Generalized Pustular Psoriasis With Apremilast

Takako Tsukamoto1, Yohei Iwata1, Kazumitsu Sugiura1

  • 1Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

The Journal of Dermatology
|November 15, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
PDE4apremilastgeneralized pustular psoriasispsoriasistransplantation

More Related Videos

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

748

Related Experiment Videos

Last Updated: Jan 11, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.4K
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

748

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

447
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
447

Articles linked to this work by shared authors, journal, and citation graph.

Pustular Mycosis Fungoides Triggered by Systemic Interferon-γ.

The Journal of dermatology·2026

Complications and Laboratory Test Findings Among Patients With Generalized Pustular Psoriasis: A Retrospective Chart Review Study.

Experimental dermatology·2026

Three-Year Follow-Up of the PACI Randomized Controlled Trial (PACI-ON): Effects of Early Intervention for Atopic Dermatitis on Atopic March.

Allergy·2026

AID Expression in Vulvar SCC Arising From Lichen Sclerosus et Atrophicus: A Retrospective Study.

The Journal of dermatology·2025

Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan.

The Journal of dermatology·2025

Clinical Significance of Serum Levels of Anti-Nuclear Matrix Protein 2 Antibodies in Patients With Dermatomyositis.

The Journal of dermatology·2025

Three Cases of Merkel Cell Carcinoma Treated With Lutetium-177 Oxodotreotide.

The Journal of dermatology·2026

Local Low-Frequency Vibration Enhances Wound-Healing and Modulates Cellular Senescence in Tissues and Exudates in a Hyperglycemic Rat Model.

The Journal of dermatology·2026

Amenamevir Transfer into Breast Milk in Patients with Herpes Simplex Virus Infection: A Brief Report of a Prospective Multicenter Study.

The Journal of dermatology·2026

From Pustules to Pruritus: A Novel IL36RN Frameshift Variant Reveals a Triple Biologic Paradox and a Th17-To-Th2 Phenotypic Transition.

The Journal of dermatology·2026

Eosinophil-To-Lymphocyte Ratio and Neutrophil-To-Lymphocyte Ratio in Erythroderma: An Exploratory Subtype-Stratified Pilot Study.

The Journal of dermatology·2026

RETRACTION: Comparative Efficacy of Janus Kinase Inhibitors Indicated for Severe Alopecia Areata: A Bayesian Network Meta-Analysis and Matching-Adjusted Indirect Comparison.

The Journal of dermatology·2026

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Therapie·2026

Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.

Handbook of experimental pharmacology·2026

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?

The Journal of clinical endocrinology and metabolism·2026

Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

Nephron·2026

Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.

Immunity, inflammation and disease·2026

Intranasal midazolam vs mouth-dissolving clobazam in terminating seizures: A randomized controlled trial.

Epilepsia·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us